Parties, taking into account the health needs and available resources, should take appropriate measures to ensure that within their jurisdiction the equal access to medical service quality. In doing so, the interests and welfare of the individual prevail over the sole interest of the whole of society or science.

The situation on the in-vitro fertilization and embryo transfer, adopted by the 39 th World Medical Assembly (Madrid, Spain, October 1987) states that:

In-vitro fertilization and embryo transfer are medical techniques available in many parts of the world, for the treatment of infertility. This method may be useful both for individual patients and for society as a whole, not only by regulating infertility, but also contributing to the disappearance of genetic diseases and the promotion of fundamental research in human reproduction and contraception.

From an ethical and scientific point of view health care to human reproduction is justified in all cases of infertility, which is not the classical medical or surgical treatment.

In all these cases, the doctor can act only with the full and informed consent of donors and recipients. The doctor must operate primarily in the interests of the child who is born as a result of the procedure.

The procedure of artificial insemination VMA welcomes and supports the fertilization in-vitro. In the situation indicated the possible ethical and legal conflicts in the use of donor eggs, sperm and embryos. However, in general, the use of donor material in the process of in-vitro fertilization was not only not prohibited, but also supported, drawing attention to the need to respect the national law in the process.

Do not deny the possibility of using the so-called replaced Parenthood, when a woman gives her consent to artificial insemination to conceive a child, which will be subsequently adopted by the man or his wife. Censure WMA is about the conduct of procedures related to in-vitro fertilization on a fee basis.

Customer relationship and a surrogate mother, in principle, not condemned VMA.Esli employer assumes the cost of the surrogate mother during pregnancy, thus ensuring the best possible treatment for the development of the fetus, this interpretation of the financial cost the customer well with the principles situation.